Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

SciSparc Ltd. Ordinary Shares (SPRC)

https://www.scisparc.com

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/27/2021

Market Cap

894,442

Shares Outstanding

520,000

Weighted SO

523,778

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ONCS --.--%

VRAX --.--%

HILS --.--%

ZVSA --.--%

UNCY --.--%

QNRX --.--%

CDIO --.--%

PXMD --.--%

YS --.--%

Beta

1.1120

Last Div

0.0000

Range

0.301-14.22

Chg

-0.0341

Avg Vol

2550220

Mkt Cap

894442

Exch

NASDAQ

Country

IL

Phone

972 3 715777

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

0.3107

EV Multiple

0.2216

P/FV

0.0191

Div Yield %

0.0000

P/E

-0.0283

PEG

-0.0019

Payout

0.0000

Current Ratio

4.1025

Quick Ratio

3.6302

Cash Ratio

1.3628

DSO

36.3859

DIO

146.3155

Op Cycle

182.7014

DPO

158.1469

CCC

24.5545

Gross Margin

0.3571

Op Margin

-2.0052

Pretax Margin

-2.0358

Net Margin

-1.7791

Eff Tax Rate

-0.0038

ROA

-0.4581

ROE

-0.8748

ROCE

-0.6007

NI/EBT

0.8739

EBT/EBIT

1.0152

EBIT/Rev

-2.0052

Debt Ratio

0.0068

D/E

0.0100

LT Debt/Cap

0.0031

Total Debt/Cap

0.0099

Int Coverage

-5.4720

CF/Debt

-77.4605

Equity Multi

1.4686

Rec Turnover

10.0314

Pay Turnover

2.3080

Inv Turnover

2.4946

FA Turnover

26.6574

Asset Turnover

0.2575

OCF/Share

-14.8099

FCF/Share

-14.8099

Cash/Share

12.9332

OCF/Sales

-2.0448

FCF/OCF

1.0000

CF Coverage

-77.4605

ST Coverage

-113.2115

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.0191

P/B

0.0191

P/S

0.3107

P/E

-0.0283

P/FCF

-0.1519

P/OCF

-0.0246

P/CF

-0.0246

PEG

-0.0019

P/S

0.3107

EV Multiple

0.2216

P/FV

0.0191

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Aug 16, 20:30 SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million GlobeNewswire Inc. Jan 19, 09:28 SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million GlobeNewswire Inc. Dec 07, 09:05 SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel GlobeNewswire Inc. Dec 01, 08:14 Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial GlobeNewswire Inc. Nov 28, 08:55 SciSparc Adopts Limited Duration Shareholder Rights Plan GlobeNewswire Inc. Nov 27, 08:41 SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform GlobeNewswire Inc. Nov 24, 08:55 New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder GlobeNewswire Inc. Nov 24, 08:55 New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder Benzinga Nov 22, 14:33 Gold Moves Lower; SciSparc Shares Spike Higher GlobeNewswire Inc. Nov 22, 07:42 SciSparc Signs Non-Binding Letter of Intent to Merge with Leading Vehicle Importer Company in Israel GlobeNewswire Inc. Nov 10, 09:10 SciSparc Aims to Change Tourette Syndrome Treatments; Will Start a Phase IIb Trial with its Innovative Pharma-Grade THC-Based Medication Benzinga Oct 31, 14:32 Dow Gains 50 Points; Global Payments Posts Upbeat Earnings Benzinga Oct 31, 14:32 Dow Gains 50 Points; Global Payments Posts Upbeat Earnings GlobeNewswire Inc. Oct 31, 07:38 SciSparc Granted Patent from the Australian Patent Office for its Reduction of Opioids Use in Pain Management Technology

Revenue Product Segmentation